Advertisement
News
Advertisement

Burrill & Company and Infinity Group Form Joint Venture Focusing on Life Science Opportunities in China

Tue, 10/12/2010 - 9:32am
Bio-Medicine.Org

SAN FRANCISCO and HONG KONG, Oct. 12 /PRNewswire/ -- Burrill & Company, a leading life sciences venture capital/private equity firm and Infinity Group, an RMB fund pioneer and the leading cross border China dollar and RMB private equity fund announced today that they have established a strategic partnership . The mandate of the joint venture will be to pursue life science investment opportunities in China; Burrill and Infinity will co-invest as equal partners in US dollar and RMB investments.

Infinity's China expertise and network, currently spanning ten well developed cities in China, combined with Burrill & Company's US and global experience and networks create an unparalleled, China-focused, life sciences partnership.  Under the terms of the partnership agreement, Burrill will establish headquarters for its China operations in Hong Kong where Infinity already has an established presence; it will also utilize all 10 of Infinity's offices in Greater China as well as its international offices located in the United States, Europe and Asia. Infinity will strengthen its presence in the United States through this cooperation, which is part of Infinity's strategy to enhance its position as a global life science fund bringing innovative technologies from Israel, the US and Europe to China. 

"We are very excited about this joint venture as this partnership will be able to build upon our complementary focus areas internationally," said G. Steven Burrill, CEO, Burrill & Company, a San Francisco based global leader in life sciences with activities in private equity, venture capital, merchant banking and media. "We will be able to bring our venture capital/private equity operations with our focus on innovation to delivery in healthcare, as well as activities in life sciences publications and events to Infinity's extensive operations and networks in China."  

"We have developed a unique and unparalleled network of partnerships

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading